Analysis of high risk factors and prognosis of patients with ventilator associated pneumonia treated with mechanical ventilation in ICU / 中国基层医药

ABSTRACT

Objective To analyze the high risk factors and prognosis of patients with ventilator associated pneumonia(VAP) treated with mechanical ventilation(MV) in Intensive Care Unit(ICU),and to provide theoretical evidence for effective treatment and prevention. Methods From January 2015 to January 2017,156 MV patients treated in ICU of Shaoxing Municipal Hospital were enrolled retrospectively.According to the occurrence of VAP,the patients were divided into VAP group(76 cases) and non-VAP group(80 cases).The data including sex,age,ICU time,MV time, cases of withdrawing machine failure, prognosis, serum albumin, blood glucose levels, APACHE Ⅱscore,types of antibiotics and days of continuous applying were recorded. Single factor χ2 test and multiple factor logistic regression analysis were used to analyze the high-risk factors and prognosis related to occurrence of VAP. Results Univariate analysis showed that the age, mortality, serum albumin and blood glucose levels, MV time, weaning failure rate,APACHE Ⅱ score,antibiotic combination type and days of continuous use,application of H2 receptor antagonists time between,the VAP group and non-VAP group had statistically significant differences (χ2 =6.568,16.558,5.132,5.896,27.043,15.018,48.863,46.752,27.431,3.981,P=0.010,0.000,0.023,0.015, 0.000,0.000,0.000,0.000,0.000,0.046). After age adjustment,logistic regression analysis showed that serum albumin <30g/L, blood glucose ≥7. 8mmol/L, MV time >5 days, APACHE Ⅱ score >15 points, antibiotics continuous use>3 days, and antibiotic combination type >2 were independent risk factors for VAP ( χ2 =5.115, 5.984,21.252,18.043,9.008,14.545,P=0.030,0.026,0.000,0.000,0.007,0.001).Compared with surviving patients with VAP, death patients lived longer in ICU and MV, and APACHE Ⅱ scores were higher ( t =4.136, 6.382,7.312,P=0.000,0.000,0.000).Conclusion There are multiple high-risk factors of VAP in patients treated with MV in ICU.The death demonstrated longer ICU time,MV time and higher APACHEⅡscore,need to be strengthened monitoring,early prevention and treatment.